Status:
COMPLETED
Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty
Lead Sponsor:
Centre Hospitalier Universitaire de Tivoli
Conditions:
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to assess the effectiveness of Sublingual Sufentanil Tablets System (SSTS, Zalviso ®) to control postoperative pain after total knee arthroplasty in the context of early rehab...
Detailed Description
Even with multimodal analgesia (combining local anesthetic infiltration, corticosteroids, non-steroidal anti-inflammatory drugs and acetaminophen), total knee arthroplasty is associated with acute mod...
Eligibility Criteria
Inclusion
- Adult patients (age ≥ 18 years)
- Scheduled for unilateral total knee arthroplasty under spinal anesthesia
- American Society of Anesthesiologists (ASA) class 1-3
Exclusion
- Contraindication to medication used in our multimodal analgesia protocol (solumedrol, celecoxib, acetaminophen, ropivacaine)
- Allergy to study medications
- History of addiction or preoperative chronic use of opioids
- Unicompartmental or revision knee replacement
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2018
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04448457
Start Date
September 1 2017
End Date
July 31 2018
Last Update
June 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Tivoli
La Louvière, Belgium, 7100